EA201070877A1 - Селективный антагонист опиоидных рецепторов каппа - Google Patents
Селективный антагонист опиоидных рецепторов каппаInfo
- Publication number
- EA201070877A1 EA201070877A1 EA201070877A EA201070877A EA201070877A1 EA 201070877 A1 EA201070877 A1 EA 201070877A1 EA 201070877 A EA201070877 A EA 201070877A EA 201070877 A EA201070877 A EA 201070877A EA 201070877 A1 EA201070877 A1 EA 201070877A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- kapp
- opioid receptors
- selective antagonist
- selective
- discontinuation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Селективный антагонист опиоидных рецепторов каппа, пригодный для лечения абстинентного синдрома вследствие отмены приема этанола и тревожности и/или депрессии или шизофрении как независимых сопутствующих состояний.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08380012 | 2008-01-22 | ||
US3912108P | 2008-03-25 | 2008-03-25 | |
PCT/US2009/030811 WO2009094260A1 (en) | 2008-01-22 | 2009-01-13 | Kappa selective opioid receptor antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201070877A1 true EA201070877A1 (ru) | 2010-12-30 |
EA017484B1 EA017484B1 (ru) | 2012-12-28 |
Family
ID=40876972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201070877A EA017484B1 (ru) | 2008-01-22 | 2009-01-13 | Селективный антагонист опиоидных рецепторов каппа |
Country Status (33)
Country | Link |
---|---|
US (2) | US7709522B2 (ru) |
EP (1) | EP2252581B1 (ru) |
JP (1) | JP5345637B2 (ru) |
KR (1) | KR101172170B1 (ru) |
CN (1) | CN101925576B (ru) |
AR (1) | AR070158A1 (ru) |
AU (1) | AU2009206653B2 (ru) |
BR (1) | BRPI0907382B8 (ru) |
CA (1) | CA2713025C (ru) |
CO (1) | CO6290644A2 (ru) |
CY (1) | CY1113071T1 (ru) |
DK (1) | DK2252581T3 (ru) |
DO (1) | DOP2010000222A (ru) |
EA (1) | EA017484B1 (ru) |
EC (1) | ECSP10010365A (ru) |
ES (1) | ES2388708T3 (ru) |
HK (1) | HK1146822A1 (ru) |
HR (1) | HRP20120558T1 (ru) |
IL (1) | IL206038A (ru) |
JO (1) | JO2797B1 (ru) |
MA (1) | MA32751B1 (ru) |
MX (1) | MX2010007849A (ru) |
MY (1) | MY163014A (ru) |
NZ (1) | NZ586225A (ru) |
PE (1) | PE20091317A1 (ru) |
PL (1) | PL2252581T3 (ru) |
PT (1) | PT2252581E (ru) |
SI (1) | SI2252581T1 (ru) |
TN (1) | TN2010000306A1 (ru) |
TW (1) | TWI422369B (ru) |
UA (1) | UA100715C2 (ru) |
WO (1) | WO2009094260A1 (ru) |
ZA (1) | ZA201003908B (ru) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2252581T3 (da) * | 2008-01-22 | 2012-07-16 | Lilly Co Eli | Kappa-selektiv opioidreceptorantagonist |
AU2009206936A1 (en) * | 2008-01-22 | 2009-07-30 | Takeda Pharmaceutical Company Limited | Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
WO2013040321A1 (en) * | 2011-09-15 | 2013-03-21 | University Of Kansas | Kappa opioid receptor effectors and uses thereof |
WO2013042054A1 (en) | 2011-09-19 | 2013-03-28 | Carmel - Haifa University Economic Corporation Ltd. | Buprenorphine for the treatment of acute suicidality |
US9512105B2 (en) | 2011-12-09 | 2016-12-06 | Research Triangle Institute | 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
US9283196B1 (en) | 2013-01-30 | 2016-03-15 | MediSynergics, LLC | Cycloalkyl-diamines for CNS disorders |
AU2014268361B2 (en) * | 2013-05-24 | 2018-09-06 | Alkermes Pharma Ireland Limited | Morphan and morphinan analogues, and methods of use |
US10316021B2 (en) * | 2016-11-28 | 2019-06-11 | Pfizer Inc. | Heteroarylphenoxy benzamide kappa opioid ligands |
KR102656163B1 (ko) | 2017-03-17 | 2024-04-08 | 더 스크립스 리서치 인스티튜트 | 카파 오피오이드 수용체 길항제 및 그와 관련된 제품 및 방법 |
JP6480616B1 (ja) | 2018-02-08 | 2019-03-13 | 有限会社 ディオン光学技研 | 照準スコープ |
US11266627B1 (en) | 2021-05-04 | 2022-03-08 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
KR20240004857A (ko) | 2021-05-04 | 2024-01-11 | 얀센 파마슈티칼즈, 인코포레이티드 | 우울증 치료를 위한 조성물 및 방법 |
WO2023131921A1 (en) * | 2022-01-10 | 2023-07-13 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
WO2023131920A1 (en) * | 2022-01-10 | 2023-07-13 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
TW202400135A (zh) * | 2022-03-07 | 2024-01-01 | 美商健生醫藥公司 | 包含阿替卡普蘭之組成物 |
US20230348377A1 (en) * | 2022-03-07 | 2023-11-02 | Janssen Pharmaceuticals, Inc. | Pure forms of crystalline aticaprant |
JP7176142B1 (ja) | 2022-03-09 | 2022-11-21 | 直迪 清瀬 | 各アルコール飲用者において飲用し得るアルコール飲料の種類に対応する飲用量の上限値に関する情報を提供するシステム |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5457208A (en) | 1993-06-21 | 1995-10-10 | Regents Of The University Of Minnesota | Kappa opioid receptor antagonists |
ES2189759T3 (es) * | 1999-05-12 | 2003-07-16 | Hoffmann La Roche | Derivados de imidazoiacepina. |
WO2002029418A1 (en) * | 2000-10-05 | 2002-04-11 | Hanns Mohler | Selective anxiolytic therapeutic agents |
US6528518B2 (en) | 2000-12-21 | 2003-03-04 | The Mclean Hospital Corporation | Treatment of depression with kappa receptor antagonists |
US6974824B2 (en) | 2001-01-08 | 2005-12-13 | Research Triangle Institute | Kappa opioid receptor ligands |
KR100865410B1 (ko) * | 2002-03-28 | 2008-10-24 | 위시스 테크놀로지 파운데이션, 인크. | 진정 및 운동실조 효과가 감소된 항불안제 |
CA2499690C (en) * | 2002-09-19 | 2011-05-24 | Eli Lilly And Company | Diaryl ethers as opioid receptor antagonist |
BRPI0407616A (pt) | 2003-03-07 | 2006-02-14 | Lilly Co Eli | composto, composição farmacêutica, método para bloquear uma combinação de receptor de mu, capa, delta (heterodìmero) deste em mamìferos, método para tratar ou prevenir obesidade e doenças relacionadas, uso de um composto, e método de suprimir o apetite em um paciente em necessidade deste" |
JP2006519855A (ja) | 2003-03-07 | 2006-08-31 | イーライ リリー アンド カンパニー | オピオイド受容体アンタゴニスト |
EP1697307B1 (en) | 2003-12-12 | 2014-03-12 | Eli Lilly & Company | Opioid receptor antagonists |
CN1894240A (zh) | 2003-12-22 | 2007-01-10 | 伊莱利利公司 | 阿片受体拮抗剂 |
EP1730140B1 (en) | 2004-03-12 | 2008-06-25 | Eli Lilly And Company | Opioid receptor antagonists |
US7381750B2 (en) | 2004-03-12 | 2008-06-03 | Eli Lilly And Company | Amino-phenoxymethyl-benzamide opioid receptor antagonists |
EP1729759A4 (en) | 2004-03-12 | 2008-04-02 | Mclean Hospital Corp | SALVINORIN DERIVATIVES AND USES THEREOF |
EP1735268B1 (en) | 2004-03-15 | 2012-02-15 | Eli Lilly And Company | Opioid receptor antagonists |
WO2005090303A1 (en) | 2004-03-15 | 2005-09-29 | Eli Lilly And Company | 4- (5- (aminomethyl) -indole-1-ylmethyl) -benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
WO2007067714A2 (en) | 2005-12-08 | 2007-06-14 | The Mclean Hospital Corporation | Treatment of sequelae of psychiatric disorders |
WO2007115975A2 (de) | 2006-04-04 | 2007-10-18 | Holger Lars Hermann | Verwendung von zusammensetzungen enthaltend kappa-opioidrezeptor-antagonisten zur behandlung von dissoziativen störungen |
CN103980151A (zh) | 2006-08-09 | 2014-08-13 | 史密丝克莱恩比彻姆公司 | 作为阿片样物质受体的拮抗剂或反向激动剂的新型化合物 |
US20100222345A1 (en) | 2006-08-09 | 2010-09-02 | Caroline Jean Diaz | Novel compounds as antagonists or inverse agonists for opioid receptors |
KR20090051778A (ko) | 2006-09-08 | 2009-05-22 | 화이자 프로덕츠 인코포레이티드 | 다이아릴 에터 유도체 및 이의 용도 |
DK2252581T3 (da) * | 2008-01-22 | 2012-07-16 | Lilly Co Eli | Kappa-selektiv opioidreceptorantagonist |
-
2009
- 2009-01-13 DK DK09703808.7T patent/DK2252581T3/da active
- 2009-01-13 ES ES09703808T patent/ES2388708T3/es active Active
- 2009-01-13 CA CA2713025A patent/CA2713025C/en active Active
- 2009-01-13 AU AU2009206653A patent/AU2009206653B2/en active Active
- 2009-01-13 BR BRPI0907382A patent/BRPI0907382B8/pt active IP Right Grant
- 2009-01-13 WO PCT/US2009/030811 patent/WO2009094260A1/en active Application Filing
- 2009-01-13 KR KR1020107016401A patent/KR101172170B1/ko active IP Right Grant
- 2009-01-13 PL PL09703808T patent/PL2252581T3/pl unknown
- 2009-01-13 AR ARP090100098A patent/AR070158A1/es not_active Application Discontinuation
- 2009-01-13 NZ NZ586225A patent/NZ586225A/en unknown
- 2009-01-13 PE PE2009000036A patent/PE20091317A1/es active IP Right Grant
- 2009-01-13 SI SI200930326T patent/SI2252581T1/sl unknown
- 2009-01-13 JO JO200915A patent/JO2797B1/en active
- 2009-01-13 EP EP09703808A patent/EP2252581B1/en active Active
- 2009-01-13 MY MYPI2010003437A patent/MY163014A/en unknown
- 2009-01-13 US US12/352,869 patent/US7709522B2/en active Active
- 2009-01-13 UA UAA201008931A patent/UA100715C2/ru unknown
- 2009-01-13 CN CN2009801026504A patent/CN101925576B/zh active Active
- 2009-01-13 TW TW098101083A patent/TWI422369B/zh active
- 2009-01-13 MX MX2010007849A patent/MX2010007849A/es active IP Right Grant
- 2009-01-13 JP JP2010543182A patent/JP5345637B2/ja active Active
- 2009-01-13 EA EA201070877A patent/EA017484B1/ru not_active IP Right Cessation
- 2009-01-13 PT PT09703808T patent/PT2252581E/pt unknown
-
2010
- 2010-04-09 US US12/757,451 patent/US8173695B2/en active Active
- 2010-05-27 IL IL206038A patent/IL206038A/en active IP Right Grant
- 2010-06-01 ZA ZA2010/03908A patent/ZA201003908B/en unknown
- 2010-06-30 TN TN2010000306A patent/TN2010000306A1/fr unknown
- 2010-07-19 MA MA33041A patent/MA32751B1/fr unknown
- 2010-07-20 DO DO2010000222A patent/DOP2010000222A/es unknown
- 2010-07-22 EC EC2010010365A patent/ECSP10010365A/es unknown
- 2010-08-12 CO CO10099271A patent/CO6290644A2/es active IP Right Grant
-
2011
- 2011-01-24 HK HK11100691.9A patent/HK1146822A1/xx unknown
-
2012
- 2012-07-06 HR HRP20120558AT patent/HRP20120558T1/hr unknown
- 2012-08-24 CY CY20121100765T patent/CY1113071T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201070877A1 (ru) | Селективный антагонист опиоидных рецепторов каппа | |
EA201290940A1 (ru) | Новые соединения как селективные антагонисты рецептора nk3, фармацевтическая композиция и методы их использования при нарушениях, опосредованных nk3 рецепторами | |
HK1149928A1 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors d2 nn- | |
EP2245002A4 (en) | AMINOALKYLBIPHENYL ANTAGONISTS N, N 'DISUBSTITUTED FROM D2 RECEPTORS OF PROSTAGLANDIN | |
HK1159099A1 (en) | Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd ccr2 copd -4- | |
NO20092376L (no) | Sfingosin-1-fosfat-reseptoragonist og -antagonistforbindelser | |
ECSP12011902A (es) | Compuestos de espiropiperidina como antagonistas | |
EA200900635A1 (ru) | Антагонисты прогестеронового рецептора | |
EA201290355A1 (ru) | Спиропиперидиновые соединения в качестве антагонистов рецептора orl-1 | |
IL210000A0 (en) | Antagonists of prostaglandin d2 receptors | |
HN2010001563A (es) | Compuestos | |
BRPI1011046A2 (pt) | derivados de isoquinolin-1 (2h)-ona como inibidores de parp-i | |
CL2009000873A1 (es) | Compuestos derivados de ciclohepta[b]piridina, antagonistas del receptor de cgrp; composicion farmaceutica; y uso para el tratamiento de la migrana.b | |
BRPI0909378A2 (pt) | métodos para tratar distúrbios usando antagonista seletivo de nmda subtipo nr2b | |
DK2401270T3 (da) | Pyrazolderivater anvendt som CCR4-receptorantagonister. | |
DK2178858T3 (da) | Nye heterocycliske forbindelser som mGlu5-antagonister | |
BRPI0720078A2 (pt) | 2-aminoquinolinas como antagonistas de receptores de 5-ht(5a) | |
CO6300937A2 (es) | Derivados de 3-carboxipropil-aminotetralina y compuestos relacionados como antagonistas de receptores opioides mu | |
BRPI0914779A2 (pt) | derivados de pirrolidina como antagonistas de receptor de nk2 | |
EA201490938A1 (ru) | Производные спиротиенопиранпиперидина в качестве антагонистов рецептора orl-1 для применения для лечения алкогольной зависимости и злоупотребления алкоголем | |
TW200833338A (en) | Compounds for the treatment of sexual dysfunction | |
DK2001456T3 (da) | Anvendelse af kappa-opiodreceptorantagonistholde sammensætninger til behandling af dissociative forstyrrelser | |
CO6531487A2 (es) | Proceso para la elaboración de compuestos orgánicos | |
DK2257534T3 (da) | 3-aminoalkyl-1,4-diazepan-2-on-melanocortin-5-receptorantagonister | |
BRPI0908919A2 (pt) | Derivados de 2-aminoquinolina como antagonistas do receptor 5-ht5a |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |